Hammond J M, Hsu C J, Klindt J, Tsang B K, Downey B R
Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Biol Reprod. 1988 Mar;38(2):304-8. doi: 10.1095/biolreprod38.2.304.
To evaluate the regulation of ovarian insulin-like growth factor-I (IGF-I) during follicular growth in vivo, we measured the concentration of this peptide in follicular fluid (FFL) of immature gilts during the induction of follicular development by pregnant mare's serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG). FFL concentrations of immunoreactive (i) IGF-I were compared with those of intrafollicular steroids and with concentrations of iIGF-I, estradiol (E2), and porcine growth hormone (GH) in serum. PMSG, administered at Time 0, induced a significant (p less than 0.01), time-dependent increase in intrafollicular iIGF-I that peaked 72 h after administration of the hormone, before the administration of hCG. During the first 72 h, the changes in ovarian iIGF-I paralleled those for progesterone and E2. After the administration of hCG at 72 h, FFL levels of E2 fell, those of iIGF-I remained constant, and progesterone rose. Serum E2 concentrations paralleled those in FFL. Since serum GH and IGF-I levels rise during spontaneous puberty in some species, these levels were also monitored. However, a significant treatment effect on serum GH and iIGF-I was not demonstrated. In summary, ovarian concentrations of iIGF-I are increased by gonadotropic hormones in vivo. The absence of concomitant changes in circulating levels of iIGF-I and GH suggests that the gonadotropin effects are exerted directly on the ovary. These results, together with more abundant data regarding secretion and action of IGF-I in cultured granulosa cells, suggest that IGF-I may function in an autocrine or paracrine fashion to amplify the actions of gonadotropins at an ovarian level.
为了评估体内卵泡生长过程中卵巢胰岛素样生长因子-I(IGF-I)的调节情况,我们在孕马血清促性腺激素(PMSG)和人绒毛膜促性腺激素(hCG)诱导未成熟小母猪卵泡发育期间,测量了卵泡液(FFL)中该肽的浓度。将免疫反应性(i)IGF-I的FFL浓度与卵泡内类固醇的浓度以及血清中iIGF-I、雌二醇(E2)和猪生长激素(GH)的浓度进行了比较。在时间0给予PMSG后,卵泡内iIGF-I出现显著(p小于0.01)的、随时间的增加,在给予hCG之前,该激素给药后72小时达到峰值。在最初的72小时内,卵巢iIGF-I的变化与孕酮和E2的变化平行。在72小时给予hCG后,E2的FFL水平下降,iIGF-I的水平保持不变,孕酮水平上升。血清E2浓度与FFL中的浓度平行。由于在某些物种中,血清GH和IGF-I水平在自然青春期会升高,因此也对这些水平进行了监测。然而,未显示出对血清GH和iIGF-I有显著的治疗效果。总之,体内促性腺激素可增加卵巢中iIGF-I的浓度。iIGF-I和GH循环水平未伴随变化,这表明促性腺激素的作用是直接作用于卵巢。这些结果,连同关于培养的颗粒细胞中IGF-I分泌和作用的更多丰富数据,表明IGF-I可能以自分泌或旁分泌方式发挥作用,在卵巢水平放大促性腺激素的作用。